bpc 157 for parkinson's disease Frontiers bpc-157 parkinson's disease Bpc 157

Depression and anxiety

Molecular Characteristics Molecular Type: Synthetic growth hormone fragment research peptide Structure: Linear peptide chain Stability: High when stored under recommended laboratory conditions Molecular Weight: Sequence-dependent Molecular Stability and Storage Profile Supplied as a lyophilized powder for enhanced long-term stability Long-term storage: Store at 20C to preserve molecular integrity Sensitive to moisture and prolonged light exposure Predictable degradation above room temperature Reconstituted solutions remain stable for approximately 2448 hours under refrigeration Solubility and Reconstitution Characteristics Bacteriostatic water Sterile saline Acidic buffers Compatible analytical-grade organic solvents Technical Specifications product Name AOD9604 6mg cas 386264-39-7 purity 99% (HPLC verified) unit Size 6 mg vial form Lyophilized powder synthesis Solid-Phase Peptide Synthesis (SPPS) analytical HPLC, Mass Spectrometry, UV Spectrophotometry molecular Structure Linear peptide chain stability High when stored appropriately Analytical Validation and Quality Control High-Performance Liquid Chromatography (HPLC) purity confirmation Mass Spectrometry (MS) molecular identity and weight verification UV spectrophotometric concentration analysis Batch identity and consistency verification Endotoxin and microbial contamination screening Regulatory and Compliance Statement AOD9604 6mg is supplied strictly for laboratory research and scientific investigation

BPC-157 Research Peptide is frequently discussed through the nitric oxide system because many studies connect it to vascular and repair-associated signalling

2 A licensed provider reviews it

As an alternative to FDA-approved branded products, where appropriate, a provider may prescribe a compounded drug, which is prepared by a state-licensed sterile compounding pharmacy partner